Start Publications Pulmonary surfactant function and molecular architecture is ...
KSV NIMA

Pulmonary surfactant function and molecular architecture is disrupted in the presence of vaping additives

Year: 2023

Journal: Colloids and Surfaces B: Biointerfaces, Volume 222, 01/02/2023, page 113132

Authors: Van Bavel, Nicolas; Lai, Patrick; Amrein, Matthias; Prenner, Elmar J.

Keywords: Biophysical investigation; Brewster angle microscopy, atomic force microscopy; Lung surfactant; Surfactant dysfunction; Vaping additives

Inhalation of harmful vaping additives has led to a series of lung illnesses. Some of the selected additives such as vitamin E acetate, and related molecules like vitamin E and cannabidiol, may interfere with the function of the lung surfactant. Proper lipid organization in lung surfactant is key to maintaining low surface tensions, which provides alveolar stability and effective gas exchange throughout respiration. Physiological surfactants, such as bovine lipid extract surfactant used to treat neonatal respiratory distress syndrome, serve as a good model for examining the potential effects of vape additives on proper function. We have found that all additives impede the surfactants’ ability to efficiently reach high surface pressures as these systems displayed numerous shoulders throughout compression with accompanying defects to lipid organization. Moreover, the formation of lipid bilayer stacks in the film are hindered by the additives, most notably with vitamin e acetate. Loss of these stacks leave the film prone to buckling and collapse under high compression that occurs at the end of expiration. The data suggest that the additives may interfere with both proper lipid organization and the surfactant protein function.